KITE PHARMA INC's ticker is KITE and the CUSIP is 49803L109. A total of 252 filers reported holding KITE PHARMA INC in Q3 2017. The put-call ratio across all filers is 1.40 and the average weighting 1.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2017 | $5,966,000 | -28.7% | 57,550 | -46.0% | 0.11% | -30.9% |
Q1 2017 | $8,364,000 | -21.1% | 106,550 | -55.0% | 0.16% | -33.3% |
Q4 2016 | $10,606,000 | +58.8% | 236,550 | +97.9% | 0.24% | +50.9% |
Q3 2016 | $6,678,000 | -25.6% | 119,550 | -33.4% | 0.16% | -30.9% |
Q2 2016 | $8,978,000 | +42.0% | 179,550 | +29.6% | 0.23% | +47.5% |
Q1 2016 | $6,324,000 | -18.5% | 138,500 | +9.9% | 0.16% | -24.0% |
Q4 2015 | $7,764,000 | +58.1% | 126,000 | +42.9% | 0.21% | +71.9% |
Q3 2015 | $4,911,000 | +11.9% | 88,200 | +22.5% | 0.12% | +33.0% |
Q2 2015 | $4,390,000 | -4.9% | 72,000 | -10.0% | 0.09% | -2.2% |
Q1 2015 | $4,615,000 | +11.2% | 80,000 | +11.1% | 0.09% | +6.9% |
Q4 2014 | $4,152,000 | – | 72,000 | – | 0.09% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Wildcat Capital Management, LLC | 2,410,034 | $433,348,000 | 77.71% |
COWEN INC. | 4,200,600 | $755,310,000 | 26.72% |
Tyrus Capital S.A.M. | 1,314,812 | $236,416,000 | 18.49% |
OMNI PARTNERS LLP | 661,711 | $118,982,000 | 15.19% |
FNY Partners Fund LP | 379,510 | $68,239,000 | 11.61% |
EQUITEC PROPRIETARY MARKETS, LLC | 240,100 | $43,172,000 | 10.15% |
EQUITEC PROPRIETARY MARKETS, LLC | 227,500 | $40,907,000 | 9.62% |
GARDNER LEWIS ASSET MANAGEMENT L P | 773,817 | $139,140,000 | 8.89% |
Quad Capital Management Advisors LLC | 192,537 | $34,620,000 | 7.10% |
Avoro Capital Advisors LLC | 496,983 | $89,363,000 | 6.93% |